Micofenolato De Mofetil Accord (Mycophenolate Mofetil)

Mycophenolate Mofetil is used in the management of immune‑mediated conditions where inhibition of lymphocyte proliferation is required.

• Kidney transplant: helps prevent acute and chronic graft rejection.
• Heart transplant: reduces the risk of organ rejection post‑surgery.
• Liver transplant: supports long‑term graft survival by suppressing immune response.
• Lupus nephritis: diminishes renal inflammation and preserves kidney function.

• Mycophenolate Mofetil is converted intracellularly to mycophenolic acid, which selectively inhibits inosine monophosphate dehydrogenase (IMPDH). This blockade reduces guanosine nucleotide synthesis, a critical pathway for the proliferation of T and B lymphocytes, thereby attenuating the immune response that leads to graft rejection or autoimmune kidney damage.

Adverse reactions may occur with Mycophenolate Mofetil therapy.

Common Side Effects

• Nausea: mild to moderate gastrointestinal upset.
• Diarrhea: frequent loose stools, sometimes leading to dehydration.
• Headache: transient cranial discomfort.
• Abdominal pain: cramping or discomfort in the stomach area.
• Tremor: fine shaking of the hands or limbs.

Serious or Rare Side Effects

• Leukopenia: significant reduction in white blood cells, increasing infection risk.
• Hepatic dysfunction: elevated liver enzymes or hepatitis.
• Opportunistic infections: severe infections such as cytomegalovirus or fungal disease.
• Malignancy: increased risk of certain cancers with long‑term use.
• Severe allergic reaction: rash, swelling, or anaphylaxis.

Patients receiving Mycophenolate Mofetil should be monitored closely for safety concerns.

• Monitor blood counts: regular CBC to detect leukopenia or anemia.
• Assess liver function: periodic liver enzyme tests for hepatotoxicity.
• Avoid in pregnancy: drug is Category D; use effective contraception.
• Use caution in renal impairment: dose adjustment may be required.
• Counsel on infection risk: advise prompt reporting of fever or signs of infection.
• Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Mycophenolate Mofetil can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid)

• Azathioprine: additive bone‑marrow suppression.
• Cyclosporine: increased mycophenolate exposure, raising toxicity risk.
• Tacrolimus: synergistic immunosuppression, heightening infection risk.
• Live vaccines: may cause severe infection; avoid administration.

Moderate Interactions (Monitor Closely)

• Antacids (aluminum or magnesium): may reduce absorption of mycophenolic acid.
• Rifampin: induces metabolism, decreasing drug levels.
• Cholestyramine: binds drug in gut, lowering systemic exposure.
• NSAIDs: can exacerbate renal toxicity when combined.